Ratio Therapeutics closes $70 million Series C financing to advance clinical development and expand manufacturing infrastructure.
Amount Raised
$70 Million
Round Type
Series C
BostonBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
Ratio Therapeutics, Inc. announced the closing of a $70 million Series C financing. The financing included participation from both existing and new investors. Proceeds will be used to advance the ATLAS study and expand the company's pipeline and manufacturing capabilities
Quick answer
Ratio Therapeutics raised $70 Million in a Series C round, dated July 31, 2026. Investors: Wasatch Group, Eli Lilly And Company, Catalio Capital Management, Bristol Myers Squibb and Duquesne Family Office. Ratio Therapeutics is based in Boston, Massachusetts, United States.
- How much did Ratio Therapeutics raise?
- Ratio Therapeutics raised $70 Million in a Series C round on July 31, 2026.
- Who invested in Ratio Therapeutics?
- Wasatch Group, Eli Lilly And Company, Catalio Capital Management, Bristol Myers Squibb and Duquesne Family Office are named as investors in this round.
- What does Ratio Therapeutics do?
- Ratio Therapeutics Inc. is a clinical-stage pharmaceutical company with the mission to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment..
- Where is Ratio Therapeutics based and how big is it?
- Ratio Therapeutics is based in Boston, Massachusetts, United States. Fundz records about 83 employees.
- Who are the decision-makers at Ratio Therapeutics?
- Fundz holds 1 contact at Ratio Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Ratio Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Cerenome, Inc. raised $20M (Debt Financing) on September 10, 2026.
- Cerenome, Inc. raised $3M (Post-IPO Equity) on September 10, 2026.
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised $6.4M on September 8, 2026.
- Dimerix Limited raised $25M (Debt Financing) on September 4, 2026.
- N-Power Medicine raised $32M (Series B) on September 1, 2026.
- Redx raised $36M (Series A) on August 27, 2026.
Who to call at Ratio Therapeutics, and when
A new round usually means Ratio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ratio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ratio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ratio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ratio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ratio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.